Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-16-107167)

Filing Details

Accession Number:: 0001104659-16-107167
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-23 16:31:06
Reporting Period:: 2016-03-22

Filing Date:: 2016-03-23
Accepted Time:: 2016-03-23 16:31:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1626199	Nivalis Therapeutics Inc.	NVLS	Pharmaceutical Preparations (2834)	208969493

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1644975	Jon Congleton	C/O Nivalis Therapeutics, Inc. 3122 Sterling Circle, Suite 200 Boulder CO 80301	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-03-22	5,000	$4.38	10,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price recorded in Column 4 represents the actual price for the full block purchase.